BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 5:16 pm Sale | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | BIOTECHNOLOGY VALUE FUND L P | 50 1.000% | -3,079,105 (-100.00%) | Filing |